Company News

Share this article:

Roche sued Mylan to prevent the latter from marketing a generic version of its Xeloda breast cancer treatment. According to a Bloomberg report, Xeloda pulled in over $1 billion in sales last year. The drug is also indicated as a treatment for colon cancer following surgery.

 

Spectrum Science Communications, a Washington DC-based health and science communications firm, is refining its name and rebranding itself as Spectrum. The company opened an office in New York, and has invested resources in digital media, consumer marketing and health policy, and added a research partner.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.